Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Not secret accumulators, bp, ot family adding. Can you prove it is not former? So it could be ....
22% or so. Problem with penny stocks ...the pennies matter. Like those $.38 buys - now down over 20%. Can always average down I guess ... there is a bottom somewhere. Then the RS
Yes section 382 is a complicated bit of tax code, with specific intent to limit acquisitions that maximize NOLs.
those look like balance sheet items. What do they have to do with P&L
Also, they didn't miss so big...they "were held up by a third party tester and the sales figures were delayed
yes 2-3x revenue. Range based on net. avid net will be less than peers (as will its marketcap) as they must carry pphm expenses/burden. So even at $100m ( a long way from here) more like $200m. That's still $.75-$.8 so a good deal for the $3x buyers. And far from a given that they are at $100m in 2 years.
And yes, I think $10mil profit within 20 months is reasonable.
They missed topline revenues , that has nothing to do with buying equipment. This wasn't a small miss this was a huge miss. They can't be running a basic mfg. company, with quarterly projections of sales and profit and miss so big. And you said they intentionally withheld the revenue.
Manufacturing is more like 15-20 and that is based on profit margin. pphm margin will have to be less than industry peers as avid must carry pphm staff and facilities. Just basic math.
Now test kit revenues and $10m accumulated profit within 20mo? You realize the company has forecasted nothing like this. Just made up numbers. And mfg . Pe ratio much lower. 2x sales would be very generous for avid/pphm when/if they turn a profit.
SK reported the events to the authorities... and the FDA also investigated the CSM swapping of trial drugs. The FBI has a history of closing cases and opening them back up
It was suggested that the revenues were withheld intentionally for the quarter. yes that would be illegal.
In the botched PII, there was so much exposure, investigation, civil discovery. Yet no criminal charges. pphm never claimed any such thing either. In the end they settled for what was likely less than their legal fees. Clearly they did not have a slam-dunk financial case, and no criminal case.
I think that the last quarter stuff was done on purpose
overall profitability means for the entire company. Not for the entire annual period. Seems clear to me. But the bigger issue is why anyone believes this. They will need to absorb all of the headcount and facility cost of pphm. They will need to add staff for the expanding book of business and facilities (should this happen). The model makes no sense frankly. Split off AVID show the real p&l. Promises from pphm are as valuable as a share of pphm - not very. All is good for everyone? Most people here have a basis well north of $1. avid showing some profit in 20 months not going to help them and 20 months is hardly a "reasonable timeframe"
Changes the game for people who bought in the $.30's perhaps but not for most here. Time will tell but history is not on the side of believing pphm long term estimates. Heck they can't even come close to their current qtr. top line revenue forecasts. A huge miss last quarter.
Our ultimate goal remains to reach overall profitability within the next 21 months
Anyone who has ever been a CEO thinks/talks annual profitability.
They didn't say they would be profitable on an annual basis. They said they would be profitable. The implication is that the quarter not year would be profitable - in 20 months. Hard to see how they even do that while having to carry all of the pphm staff and facilities.
It will likely go lower there is little reason to buy with RS pending. $3.50? Not without a deal or big trial success. Avid maybe being profitable in 20 months not near enough for a 10x move.
Yes, wander into the pphm web. This is such a perfect time to buy with the RS next on deck.
Use common sense is good advice. Common sense CLEARLY points to the stock being down for reasons of:
- Failed Sunrise
- No trials
- no products
- pending RS
- sleazy bod
- no institutional support
- track record of failure
There is no proof of any lid etc.
ask yourself why would any negative views about Peregrine not ever mention about the sabotage attempts??
Well that is certainly carefully choosing facts. Facts are bavi has failed every late stage trial. Most of the foremost investors including bio-experts do not believe it has commercial viability ($.33) The fact that it is interesting technology does not equal success or shareholder value.
patents only useful if something works. I see no relevant avid patents. Have you seen shareprice, clearly no one thinks ip has value at this point.
science and Avid things have never looked better at PPHM
revenues don't pay back costs, profits do. How much has avid earned ....no one knows, that's a problem. If pphm future is avid they need to open up the books.
Avid has no proprietary equipment, methods, supplier etc. Anyone can build an Avid facility.
So ONE Avid facility produces 1000 times more then a comparable competing one and costs 90% less to set-up.
Bavituximab proved it worked in several Breast Cancer clinical trials, in NSCLC PII and performed as expected in the Sunrise PIII.
Unfortunately both last mentioned trials where the victim to unforeseen incidents.
I guess that means the bp's are uniformed, hedge funds with there bio expertise are uniformed (real expertise not gadflies) oh and pphm is also uninformed guess as they speak nothing of this.
But opinions can be informed, take into account past track record, experts in industry, professionals (investors and scientific) or they can be emotional and based on your entry price and losses.
You are creating linkages where none exists. These are "do you walk to school or takes your lunch," types of comments. As for partnering all facts would point to lack of interest. Pphm is holding out for a better price? With another RS pending and shareprice at $.33?
Some Billionaire will step forward
all very fixable with the stroke of a pen...
get a deal done...
I let these PR from PPHM do the talking
Accumulation has been going on for quite some time, likely as long as March 2014
but everyone should realize that NCCN wants to be in the top position when Immunotherapy breaks free and in great demand for PS Targeting treatments, so they will want to have all the trials set up and ready to go
They will spend tenfold what PPHM contributed.
But what should also be of interest, is NCCN does not just bring PS Targeting on board for a non-astronomical reason
thought they had a slam dunk
The $2m was to fund the grants that are the trials. Some drugs are being "donated" as well. But pphm is paying others to do the trials - no other way to spin this. Still a good idea, mainly because they get others involved since pphm clearly can not handle this on their own.